BlackRock
RKDA icon

BlackRock’s Arcadia Biosciences RKDA Stock Holding History

BlackRock’s Portfolio RKDA Stock Details RKDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-38
Closed -$119 – 5368
2023
Q4 		$119 Hold
38
– – ﹤0.01% 5328
2023
Q3 		$127 Hold
38
– – ﹤0.01% 5392
2023
Q2 		$147 Hold
38
– – ﹤0.01% 5455
2023
Q1 		$284 Sell
38
-717
-95% -$7.61K ﹤0.01% 5505
2022
Q4 		$8.19K Sell
755
-15
-2% -$214 ﹤0.01% 5486
2022
Q3 		$16K Sell
770
-21
-3% -$716 ﹤0.01% 5545
2022
Q2 		$31K Sell
791
-682
-46% -$31.4K ﹤0.01% 5497
2022
Q1 		$82K Sell
1,473
-70
-5% -$3.34K ﹤0.01% 5328
2021
Q4 		$65K Buy
1,543
+76
+5% +$4.96K ﹤0.01% 5367
2021
Q3 		$121K Sell
1,467
-31
-2% -$2.91K ﹤0.01% 5095
2021
Q2 		$178K Buy
1,498
+846
+130% +$92.2K ﹤0.01% 4918
2021
Q1 		$72K Buy
652
+69
+12% +$8.46K ﹤0.01% 4875
2020
Q4 		$59K Buy
583
+46
+9% +$5.62K ﹤0.01% 4651
2020
Q3 		$61K Sell
537
-25
-4% -$3.38K ﹤0.01% 4586
2020
Q2 		$85K Buy
562
+557
+11,140% +$86.6K ﹤0.01% 4511
2020
Q1 		$1K Hold
5
– – ﹤0.01% 4919
2019
Q4 		$1K Hold
5
– – ﹤0.01% 4944
2019
Q3 		$1K Hold
5
– – ﹤0.01% 4932
2019
Q2 		$1K Hold
5
– – ﹤0.01% 4978
2019
Q1 		$2K Hold
5
– – ﹤0.01% 4837
2018
Q4 		$1K Hold
5
– – ﹤0.01% 4902
2018
Q3 		$1K Hold
5
– – ﹤0.01% 4954
2018
Q2 		$2K Hold
5
– – ﹤0.01% 4915
2018
Q1 		$5K Hold
5
– – ﹤0.01% 4728
2017
Q4 		$1K Hold
5
– – ﹤0.01% 4880
2017
Q3 		$2K Sell
5
-7
-58% -$2.56K ﹤0.01% 4854
2017
Q2 		$4K Sell
12
-36
-75% -$20.1K ﹤0.01% 4826
2017
Q1 		$27K Buy
+48
New +$34.5K ﹤0.01% 4562

Other funds holding RKDA

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
OLVIG
Oliver Lagore Vanvalin Investment Group Flint, Michigan $255M AUM

BlackRock's RKDA Position: Q1 2024 in Review

BlackRock sold out of Arcadia Biosciences (RKDA) in Q1 2024, closing a stake of 38 shares — an estimated $119 sold.

BlackRock first reported a position in RKDA in Q1 2017 and held it in 28 quarters. The position peaked at $178K in Q2 2021. 14 funds tracked by Wall St. Rank hold RKDA as of Q1 2024.

  • BlackRock reported no remaining Arcadia Biosciences position as of Q1 2024 after selling out during the quarter.
  • BlackRock sold 38 Arcadia Biosciences shares in Q1 2024, an estimated $119.
  • BlackRock first reported a position in Arcadia Biosciences in Q1 2017 and held it in 28 quarters.
  • BlackRock's Arcadia Biosciences position peaked at $178K in Q2 2021.
  • 14 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q1 2024.

Based on BlackRock's 13F filing for Q1 2024, filed 10 May 2024.